S1PR2 and Cognitive impairment: In addition, we hypothesized that the enhanced activation of S1PR2 would contribute to glial activation, neuroinflammation in the hippocampus, altered membrane expression of AMPA and NMDA receptors, and cognitive impairment in hyperammonemic rats and that blocking S1PR2 with JTE-013 would reverse all of these effects.